@SaynaNorouzi@BradRovin@OhioStateNeph@GlomCon The envision trial looks sus😳; gfr drop in placebo arm way higher than other studies. Would it hv magnified the effect diff in treatment arm?
@theliverdoc Liked Oddity and longlegs. Oddity was very atmospheric. But, I believe Hereditary takes the cake. The acting was also top notch. Try Ritual and The Bucket list as well.
PEXIVAS - The groundbreaking results of this trial are finally out!! A quick recap of some of the landmark trials in vasculitis
⚫INDUCTION TRIALS
☑️ NORAM
☑️ CYCLOPS
☑️ RAVE
☑️ RITUXIVAS
☑️ MEPEX
☑️ MYCYC
☑️ CORTAGE
Study shows tolvaptan improves diuresis even in CKD 5!. I used to stop vaptans in pts with impaired gfr. Maybe start using it even in CkD?
https://t.co/MlNw6XM9ZV
1/
I once heard that a fever in the ICU was a "fever of too many origins."
Same can be said altered mental status/encephalopathy!
We put together a comprehensive approach to these challenging patients for #SeminarsinNeurology
A thread with our approach!
https://t.co/VK9Dm1v8iQ
More welcome news in IgAN: APRIL inhibitor sibeprenlimab reduces proteinuria at month 9 interim analysis in VISIONARY (~530 patients with IgAN at high risk of progression)
Ongoing follow up for 2 year GFR slope endpoint - final results expected early 2026 https://t.co/IU6hCJzULI